Opinion

Video

Overcoming Key Operational Challenges in Integrating Bispecific Therapies

Experts discuss the most common logistical challenges encountered when implementing bispecific therapies as well as the primary barriers smaller community practices face in operationalizing bispecific antibody treatments.

Video content above is prompted by the following:

  1. What are the most common logistical challenges you encounter when implementing bispecific therapies?
  2. What are the primary barriers that smaller community practices face in operationalizing bispecific antibody treatments?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Carrie Kitko
Dr Ibrahim Aldoss
1 expert is featured in this series.
Miriam Freimer, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo